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Abstract
The manifestations of multiple myeloma are protean and related to bony osteolytic lesions, and to medullar and
renal insufficiency. We report a patient who presented with otalgia as the inaugural symptom of multiple
myeloma. Local irradiation combined with systemic chemotherapy led to the disappearance of the temporal
bone mass and the accompanying symptoms. To date, 24 months after the diagnosis, the patient is still in
remission.
The literature on otological involvement in multiple myeloma is reviewed. Symptoms are non-specific and
include hearing loss, tinnitus, dizziness, facial paralysis, and otalgia. The diagnosis of multiple myeloma should
be considered in the presence of a temporal bone mass.
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Introduction
Multiple myeloma (MM) accounts for 10 per cent of
haematological malignancies and one per cent of all
cancer-related deaths (Alexian and Dimopulos, 1994;
Bataille and Harousseau, 1997). MM is a neoplastic
proliferation of monoclonal plasma cells within the
haematopoietic bone marrow. Symptoms are related to
these osteolytic lesions (skeletal pain, pathological frac-
tures, hypercalcaemia), to the replacement of bone
marrow by the neoplastic process (immunosuppression
resulting in increased bacterial infections, anaemia, bleed-
ing), and to renal insufficiency.
The diagnosis of MM requires at least two of the
following criteria (Barlogie, 1995; Selby and Gore, 1995):
1) serum or urinary monoclonal immunoglobulin which
can be composed of the entire immunoglobulin protein, of
complete light chains, or various fragments; 2) bone-
marrow infiltration by large and immature plasma cells;
3) osteolytic lesions. Several staging systems have been
described (Barlogie, 1995; Selby and Gore, 1995).
Since MM is a systemic illness, involvement of the
temporal bone is possible. Nevertheless, otological symp-
toms in MM have rarely been described. A case is reported
in which the presenting signs of MM were otological. The
literature on temporal bone involvement in MM is
reviewed.
Case report
A 70-year-old male, without previous medical history,
consulted because of progressively worsening right earache
of six months duration. He did not complain of hearing
loss, tinnitus, or dizziness.
Clinical examination revealed a right external ear canal
partially obstructed by a subcutaneous, smooth mass,
located on the posterior bony-cartiligenous junction. The
tympanic membrane was intact. Tuning fork testing was
normal and symmetrical. A right peripheral facial paresis
was present.
A temporal bone computed tomography (CT) scan
(Figure la) showed an osteolytic lesion, 2.5 cm in diameter,
enhanced by contrast material, and replacing the right
mastoid. The mass eroded the posterior canal wall and
protruded in the posterior fossa. A second osteolytic lesion
was found at the level of the right occipital condyle.
These lesions exhibited homogeneous enhancement with
gadolinium on magnetic resonance imaging (MRI)
(Figure lb).
A biopsy of the external auditory canal mass was
performed under local anaesthesia. The pathology showed
a proliferation of atypical plasma cells compatible with a
multiple myeloma (Figure 2) and immunohistochemical
staining was positive for the Kappa light chains and
negative for the Lambda light chains (not shown).
Further investigations, including a skull and skeletal
X-rays, a protein electrophoresis, an immunoelectro-
phoresis and a bone marrow biopsy, permitted the
diagnosis of IgG-Kappa multiple myeloma, without renal
failure, anaemia, or hypercalcaemia. The disease was thus
staged as Ilia.
The patient was treated with Alkeran and Prednisone,
and local radiation therapy delivered through two lateral
weighted fields for a total dose of 30 Gy (6 MeV photons;
10 fractions of 3 Gy).
Three months after this treatment, the patient was
greatly improved. The otalgia and facial paralysis resolved.
The external auditory canal lesion regressed completely.
From the Departments of Otolaryngology - Head and Neck Surgery*, Pathologyt, Radiology ,^ and Medicine**, University Canton
Hospital, 24 Rue Micheli-du-Crest, 1211 Geneya 14, Switzerland.
Accepted for publication: 4 March 1998.
469
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0022215100140800
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 08:24:28, subject to the Cambridge Core terms of use, available at
470 D. QUINODOZ, P. DULGUEROV, A-M. KURT, D. RUEFENACHT, R. ABELE, A. S. ALLAL, P. MONTANDON
(a) (b)
FIG. 1
Initial axial CT and MRI scans. The CT scan, after i.v. application of contrast material, is filmed with soft tissue windows (Figure la).
The homogenous enhancing temporal bone mass presents as an osteolytic lesion of the right mastoid and sino-dural angle plate
without signs of periosteal reaction or invasion of the sigmoid sinus. A second lesion with similar radiological characteristics is
present at the base of skull near the foramen magnum. The Tl-weighted MRI image with gadolinium-DPTA (Figure lb) also
exhibits a pattern of homogeneous enhancement after contrast application.
To date, 24 months after the diagnosis, the patient does not
present any local or general complaints and has resumed
his normal activities.
Discussion
A variety of tumours, either primary or secondary, can
involve the temporal bone (Hyams, 1987; Abemayor et al.,
1988; Kemink et al., 1993). Symptoms are not specific and
tend to vary with the location of the disease process and
the invaded anatomical structures (Schuknecht, 1993).
While physical examination, audiological and vestibular
investigations are warranted, they are rarely diagnostic and
radiological studies such as thin section CT or MRI scans
FIG. 2
The lesion is composed of a dense cellular infiltrate, mainly
composed of plasma cells arranged in cords, separated by a
fibro-vascular stroma. (H & E; X 400).
are required to determine the involved structures and help
in selecting the surgical approach for excision or biopsy
(Jackler and Parker, 1992).
Involvement of the temporal bone has been reported to
occur in the terminal stage of MM. However, at this stage,
otological symptoms are overshadowed by the manifesta-
tions of diffuse skeletal disease (Schuknecht, 1993).
In our case, the presenting signs of MM were related to
an involvement of the temporal bone. The mastoid mass
resulted in otalgia and a facial palsy without any other
otological or systemic symptoms.
In the literature, only a few individual case reports
describe a symptomatic MM temporal bone involvement
(Table I). In 1979, Lavine et al. presented a patient already
diagnosed with MM, who complained of dizziness, hearing
loss and tinnitus. Three other cases with otological
symptoms in patients with diffuse signs of MM have
been published (Shone, 1985; Keay, 1988; Chevalier et al.,
1992).
Marks and Brookes in 1985 were the first to describe a
patient with left deafness, tinnitus, facial palsy, and
intermittent vertigo who had an isolated mastoid lesion.
Biopsy of the external auditory canal lesion led to the
diagnosis of MM. Funakubo and Kikuchi (1994) describe a
similar case. None of these studies included histopatholo-
gical sections of the temporal bone.
Li et al. (1994) studied the temporal bone histopathology
in eight patients who had died from advanced, dissemi-
nated MM. Among these eight patients only two had
otological symptoms, while 14 out of 16 temporal bones
(87 per cent) exhibited MM lesions in various locations.
The structures involved were exclusively bony, with
sparing of mucosa, skin and other key structures such as
the facial nerve or the carotid artery.
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TABLE I
CASES OF TEMPORAL BONE INVOLVEMENT IN MULTIPLE MYELOMA REPORTED IN THE LITERATURE
Hearing Facial
Age Sex loss Deafness Tinnitus Vertigo palsy
Systemic
Otalgia symptoms
La vine (1979)
Marks and Brookes (1985)
Shone (1985)
Keay (1985)
Chevalier et al. (1992)
Funakubo and Kikuchi (1994)
Present case
55
71
55
58
62
71
70
F
M
F
F
F
M
M
The temporal bone is, therefore, often involved in
advanced cases of MM. The clinical expression of this
involvement is, however, unusual (Table I) and only
exceptionally does MM present with otological symptoms,
as in our patient.
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